ENCRX
LIVE

Serial Number

98366145

Owner

Encellin, Inc.

Attorney

Winfield B. Martin

Filing Date

Jan 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ENCRX Trademark

Serial Number: 98366145

ENCRX is a trademark filed by Encellin, Inc. on January 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Encellin, Inc. (2 trademarks)

3150 Porter Drive
Palo Alto, CA 94304

Entity Type: 03

Trademark Details

Filing Date

January 19, 2024

Registration Date

Not Registered

Published for Opposition

November 26, 2024

Goods & Services

Pharmaceutical products for treatment of chronic diseases by means of gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for implantable cell therapy; living cells for gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for medical use, namely, encapsulated cells delivered by implantable cell therapy devices for secreting drugs and/or molecules; encapsulated pharmaceutical products for the treatment of chronic diseases; implantable pharmaceutical products for the treatment of chronic diseases; encapsulated pharmaceutical product for the treatment of chronic diseases delivered by implantable encapsulation devices with encapsulated cells for secreting drugs

Cell encapsulation devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; implantable cell encapsulation devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; implantable cell therapy devices in the nature of implantable drug and/or molecule and cell therapy delivery ports; drug and prescription encapsulation devices in the nature of implantable drug and cell therapy delivery ports; implantable drug and prescription encapsulation devices in the nature of implantable drug and cell therapy delivery ports; implantable drug and prescription delivery devices in the nature of implantable drug and cell therapy delivery ports

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 7, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 7, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 7, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 4, 2025 EXRA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 3, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 3, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 3, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 3, 2025 REAP
SOU EXTENSION 1 GRANTED
Jul 3, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 3, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 3, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 4, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 26, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 19, 2024 NWOS
NEW APPLICATION ENTERED
Jan 19, 2024 NWAP